Waltham, MA 11/30/10—Thermo Fisher Scientific has definitively agreed to acquire Lomb Scientific, a provider of laboratory chemicals, consumables and instruments in Australia and New Zealand. Financial details were not disclosed. Lomb had 2009 revenues of AUD $34 million ($27 million = AUD 1.28 = $1) and has approximately 100 employees. “The addition of Lomb Scientific […]
Phillipsburg, NJ 11/3/10—Avantor Performance Materials, formerly Mallinckrodt Baker (see IBO 5/31/10), has agreed to acquire India-based RFCL Limited from ICICI Venture Funds Management for an undisclosed amount. RFCL’s Rankem division is a provider of more than 20,000 laboratory reagents and consumables to more than 5,000 customers. RFCL’s Diagnova division offers 2,000 diagnostic products to more […]
Asslar, Germany 11/3/10—Pfeiffer Vacuum Technology AG has announced that it plans to acquires Alcatel-Lucent’s Vacuum Technology Unit, which does business under the Adixen brand name, for approximately €200 million ($279 million = €0.72 = $1). The Unit supplies vacuum pumps and leak detectors, and has a leading market position in backing pumps, according to Pfeiffer […]
Carlsbad, CA 11/2/10—Life Technologies has agreed to acquire certain assets of Indian distributor Labindia. Financial terms were not disclosed. “India has experienced strong double-digit growth in the biotechnology sector, making this one of the fastest-growing regions in Asia Pacific,” stated Mark Smedley, head of the Asia Pacific region for Life Technologies. “Our primary goal in […]
Merck KGaA stimulated the analytical instrument and laboratory product–related mergers and acquisitions (M&A) market by outbidding Thermo Fisher Scientific in February to acquire Millipore for $7.2 billion (see IBO 2/28/10). This marked the industry’s largest acquisition since Thermo Electron’s $10.6 billion merger with Fisher Scientific in 2006 (see IBO 5/15/06) and started the M&A year […]
London, England 10/21/10—RTS Life Science, a provider of laboratory sample management solutions, will be sold to Entologi for £600,000 ($946,536 = £0.63 = $1) in cash, under a proposal to shareholders by publicly held parent company Robotic Technology Systems (RTS). RTS’s other businesses, RTS Flexible Systems and RTS Thurnall, will also be sold to Entologi. […]
It was a little more than a year ago that Danaher announced the acquisition of Life Technologies’ MS business and MDS Analytical Technologies, including Molecular Devices (see IBO 9/15/10). The acquisition introduced a new player into the MS market and expanded Danaher’s business in the life science research instrument market. With 2009 revenues in excess […]
Cleveland, OH 10/1/10; Quebec City, Canada 10/1/10—EXFO has sold its Life Sciences and Industrial Division to private equity firm The Riverside Company for $24.3 million in cash. The business supplies high-intensity UV illumination products, which are used in microscopes and life science instruments, as well as curing products. It will be renamed the Lumen Dynamics […]
San Diego, CA and Ottawa, Canada 10/14/10—Fate Therapeutics announced that it has signed a three-year collaboration and licensing agreement with BD Biosciences for the development and commercialization of induced pluripotent stem cell technologies for drug discovery and development. The companies will jointly develop products that BD Biosciences will commercialize. The agreement includes exclusive licenses to […]
Santa Clara, CA 10/13/10—Cell Biosciences has agreed to acquire Convergent Bioscience for $12 million in cash. Convergent Bioscience provides systems based on imaging capillary electrophoresis for quality control measurements during protein biologics production. Based in Toronto, Canada, Convergent Bioscience has 45 employees and is expected to have 2010 revenues of close to $8 million. “Our […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
